.Sanofi has actually made an overdue entrance to the radioligand event, paying out one hundred thous...
.After F2G's initial attempt to get a new training class of antifungal to market was thwarted by the...
.Moderna has sworn to cut R&D investing through $1.1 billion through 2027. The choice to shrink t...
.Just four months after Sanofi bet $80 million in ahead of time cash on Key Therapeutics' losmapimod...
.Cancer company Oncternal Therapies is folding all its medical tests and also giving up workers, tra...
.Roche is actually holding out chances that its injectable excessive weight possibility might ultima...
.Novo Nordisk has actually raised the lid on a period 1 test of its own oral amylin as well as GLP-1...
.Simply a handful of brief full weeks after winning an FDA Fast Track tag for its investigational BT...
.Not long after a favorable data reduce for Eli Lilly's efsitora alfa, the Indianapolis-based compan...
.BridgeBio Pharma is actually lowering its genetics treatment budget plan as well as pulling back fr...